Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Selin Gerekçi"'
Autor:
Selin Gerekçi, Ali Deniz Dalgic, Yagmur Caliskan, Can Ozen, Ezgi A. Güleç, Dilek Keskin, Aysen Tezcaner
Publikováno v:
International Journal of Pharmaceutics. 557:97-104
Osteosarcoma is the most common cancer in bone. Drug resistance is a challenge of current treatments that needs to be improved with novel treatment strategies. In this research, a new dual drug delivery system was developed with Gemcitabine (GEM) and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79c766346ead0ba6767a25dfc3d4ade6
https://doi.org/10.1016/j.ijpharm.2018.12.041
https://doi.org/10.1016/j.ijpharm.2018.12.041
Autor:
Ayşenur Biber, Naşit Iğci, Can Ozen, Hepşen Hazal Hüsnügil, Selin Gerekçi, Tuğba Somay Doğan, Afife Izbirak
Publikováno v:
Turkish Journal of Biology
Volume: 42, Issue: 6 490-497
Volume: 42, Issue: 6 490-497
Protoiurus kraepelini is a scorpion species found in parts of Turkey and Greece. In this study, the peptide profile of its venomwas determined for the first time. The electrophoretic profile of the crude venom showed a protein distribution from 2 to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b923852f1a93eaa4627359cd14235e1
https://doi.org/10.3906/biy-1804-35
https://doi.org/10.3906/biy-1804-35
Publikováno v:
Amino Acids. 50:1607-1616
The second mitochondria-derived activator of caspase (Smac/DIABLO) is a pro-apoptotic protein that released from mitochondria into the cytosol when cells undergo apoptosis. Smac promotes caspase activation by binding the inhibitors of apoptosis prote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::975c2b4266574d068c7cceb2da4cda0b
https://doi.org/10.1007/s00726-018-2637-0
https://doi.org/10.1007/s00726-018-2637-0
Autor:
Can Ozen, Hazal Hepsen Husnugil, Ayşenur Biber, Selin Gerekçi, Ipek Zeynep Durusu, Ezgi A. Güleç, Heval Atas
Publikováno v:
Leukemia Research. 55:33-40
Multiple Myeloma (MM) is a malignant neoplasm of bone marrow plasma B cells with high morbidity. Clofazimine (CLF) is an FDA-approved leprostatic, anti-tuberculosis, and anti-inflammatory drug that was previously shown to have growth suppression effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be2fd355d86e0b6356e372b7a4303039
https://doi.org/10.1016/j.leukres.2017.01.019
https://doi.org/10.1016/j.leukres.2017.01.019
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ayşenur Biber, Aliye Ezgi Gulec, Selin Gerekçi, Ipek Zeynep Durusu, Can Ozen, Heval Atas, Hazal Hepsen Husnugil
Publikováno v:
Blood. 128:5897-5897
Multiple myeloma (MM) is a malignant neoplasm of bone marrow plasma B cells with high morbidity. Clofazimine (CLF) is an FDA-approved leprostatic, anti-tuberculosis, and anti-inflammatory drug that was previously shown to have growth suppression effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6ca42b758505fe8d6036c4d5eba0db0
https://doi.org/10.1182/blood.v128.22.5897.5897
https://doi.org/10.1182/blood.v128.22.5897.5897